Subject(s)
Heart Failure/diagnosis , Influenza, Human/diagnosis , Isolated Noncompaction of the Ventricular Myocardium/diagnosis , Vaccination , Heart Failure/etiology , Heart Failure/prevention & control , Humans , Influenza, Human/complications , Influenza, Human/prevention & control , Isolated Noncompaction of the Ventricular Myocardium/etiology , Isolated Noncompaction of the Ventricular Myocardium/prevention & control , Male , Young AdultABSTRACT
gamma-Glutamyltranspeptidase (GGT) activity in equine urine was measured, using an assay developed for use with serum and was found to be reproducible. The GGT activity was measured in samples prepared by serial dilution of exogenous GGT with equine urine, and the activity was determined to be linear between 21 IU/L and 407 IU/L. The behavior of exogenously added GGT was compared in equine serum and urine. The enzyme behaved similarly in both fluids. The GGT activity was measured in serum and urine samples after storage at -20, 4, and 25 C for 24 and/or 72 hours. Enzyme activity decreased after storage at all temperatures and times, but the decrease was greatest and most variable at -20 C. The urine GGT: urine creatinine ratio was calculated on serial urine samples collected over 24 hours. Although the urine GGT activity and creatinine concentration had significant variation, the ratio remained constant. The urine GGT: urine creatinine ratio was calculated from random urine samples collected from 27 clinically healthy adult horses and was found to be 10.52 +/- 4.78 (mean +/- SD).
